Doctors and nurses produce roadmap to future-proof healthcare
Report uses input from healthcare professionals to highlight training and support needs, while also warning about departures
30th March 2022
Report uses input from healthcare professionals to highlight training and support needs, while also warning about departures
30th March 2022
ProKnow was chosen to enable healthcare providers to benchmark treatment metrics against best practice and support clinical excellence
30th March 2022
Charter for Change examines reasons for inequalities and sets out recommendations to improve diabetes care
29th March 2022
Collaboration will involve the development of new class IgM antibodies with a view to gaining market approval
29th March 2022
Digital health boost as new website focuses on dry eye disease, which currently affects one in four people across the UK
28th March 2022
Collaboration between Babylon Health and tech giant seeks to speed up historically slow patient access to data
28th March 2022
STP1 has demonstrated good safety and tolerability profiles, while also showing positive results for neurological function
25th March 2022
The site in Kent will support the manufacture of regulatory approved cannabis-based medicines while also leveraging environmental practices
25th March 2022
Collaboration will focus on AI analysis of flu progression, immune responses and the development of new vaccines
24th March 2022
The platform to build a digital-ready frontline workforce will be available to all NHS and social care staff
24th March 2022
Digital-first patient care is a priority as the companies join forces to improve patients' lives
23rd March 2022
Groups including those aged over 75-years-old, care home residents and the immunocompromised will be entitled to a fourth jab
23rd March 2022
Approval of Exkivity could mean NHS access to ground-breaking treatment for patients with rare lung cancer
22nd March 2022
Patients with a life-limiting skeletal condition welcome availability of elosulfase alfa on the NHS
22nd March 2022
Patients eligible to receive Takeda’s Exkivity (mobocertinib) have a rare form of lung cancer that cannot be removed by surgery
21st March 2022